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IMMUNOLOGIC INJURY OF CULTURED CELLS
INFECTED WITH MEASLES VIRUS
I . Role of IgG Antibody and the Alternative Complement Pathway*
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(From the Departments of Immunopathology and Molecular Immunology, Scripps Clinic and
Research Foundation, La Jolla, California 92037)
Measles virus infection in man is commonly an acute, self-limiting disease not associated
with viral persistence (1) . After infection, which occurs through the respiratory tract,
measles virus replicates in respiratory epithelial cells and disseminates throughout the
body infecting lymphoid organs and other tissues . During the initial 9-14 days after
infection, there is little or no overt evidence of clinical disease . The advent of clinical
symptoms and tissue injury is thought to be, at least in part, a direct consequence of the
virus and/or virus-infected cells interacting with sensitized lymphocytes and antimeasles
virus antibody which are generated during the incubation period . Such interactions are
also recognized as prerequisites for viral clearance and clinical recovery . As convalescence
proceeds, circulating antibody to measles virus increases, and the virus becomes
undetectable . After recovery, the patient has circulating antibody and clinical resistance
to measles virus reinfection throughout life .
Other less common forms of measles virus infection are also recognized . Post-infectious
encephalomyelitis usually follows the outbreak of rash after measles virus infection (2) .
Failure to recover virus from diseased tissues associated with an inflammatory response at
the site of tissue injury has led to the suggestion that this form of measles-associated
disease is basically allergic in nature (3) . A chronic degenerative disease of the central
nervous system, subacute sclerosing panencephalitis (SSPE) ` is recognized as a late
sequel of measles virus infection (4) . In this disorder the host makes a continuous,
heightened immune response against measles virus and virus persists in various tissues .
SSPE is currently viewed as a prototype of human "slow" virus disease .
In this report we characterize interactions between cells infected with measles
virus and the humoral immune system . We have determined the time-course
required for infected cells to express cytoplasmic and surface measles virus
antigens and studied the lysis of such cells by antibody to measles virus and
complement (C) . In this in vitro model of acute measles virus infection IgG was
the only class of immunoglobulin (Ig) found to initiate injury of cells bearing
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measles virus antigens on their surface in conjunction with C and cell lysis was
found to be mediated by the alternative C pathway . In contrast, purified measles
virus in conjunction with antibody was found to activate theclassical C pathway .
Various parameters of these immune reactions were quantitated and their
implications discussed .
Materials and Methods
Virus .
￿
Wild Edmonston strain measles virus was obtained from the American Type Culture Col-
lection, Rockville, Md . After several passages at low multiplicities of infection (MOD in HeLa cells, a
pool of infectious virus was collected, separatedfrom cellular debris by centrifugation at 700 g, divided
into small aliquots, andfrozen at -70°Cuntil use. The infectious titer of this pool was 5 x 10 5 tissue
culture infective dose so U (TCIDso)/ml . Two attenuated strains of measles virus (M-VAC vaccine,
American Cyanamid Co ., Lederle Laboratories Div., Pearl River, N.Y . ; Lirugen Schwarz strain vac-
cine, DowChemical Co ., Midland, Mich.) were obtained commercially andpassed at lowMOIin HeLa
cells . SSPE virus (strain Halle) was kindly provided by Monique Dubois-Dalq, National Institute of
Neurological Diseases and Stroke, Bethesda, Md . This isolate, previously passed twice in Vero cells,
was adapted to grow in HeLa cells in our laboratory . Purified measles virus was kindly supplied by
John Holland, University of California at SanDiego, La Jolla, Calif . In brief, virus was obtained from
infected HeLa cells and freed from contamination by initial low speed centrifugation and by subse-
quent banding in 5-40% sucrose and 20-45% potassium tartrate gradients . The virus obtained was
dialyzed against barbital saline buffer with gelatin, calcium chloride, and magnesium chloride (5) .
Cell Lines .
￿
HeLa, KB, and H.Ep. no . 2 epithelial cell lines were obtained from Microbiological
Associates, Los Angeles, Calif . Human neuroblastoma cells (line IMR-32) and glioma cells (line 339
MG) were furnished, respectively, by Harvey Herschman, University of California at Los Angeles,
Calif, and Jan Ponten, University of Uppsala, Uppsala, Sweden . Human lymphocyte lines RPMI
8866 and Raji were provided by Richard Lerner, Scripps Clinic and Research Foundation, La Jolla,
Calif .
Culturing, Infecting, andHandling of Cells .
￿
HeLa, KB,H.Ep . no . 2, IMR-32, and 339MG cells
were each grown as monolayers in 75 cm 2 Falcon flasks (Falcon Plastics, Div. of BioQuest, Oxnard,
Calif.) with Eagle's minimal essential medium supplemented with 10% heat-inactivated fetal calf
serum, 1% glutamine, and antibiotics (growth medium) . Flasks were incubated at 37°C in 5% CO,
and cultures were divided weekly . Lymphocyte lines were placed in suspension cultures in Spinner's
medium supplemented with nutrients and antibiotics as above . These cultures grew in stoppered
Erlenmeyer flasks on a rocker platform at 37°C and were divided weekly .
Monolayer cells . to be infected or to be analyzed for surface immunofluorescence or cytotoxicity
were washed repeatedly in situ with phosphate-buffered saline to remove loose cells . The adherent
cells were covered with 0.05% trypsin EDTA solution (Grand Island Biological Co ., Grand Island,N.
Y.) and gently agitated at room temperature for 1-2 min until the cells were completely suspended .
After repeated washing in growth medium, such cells showed greater than 95% viability by trypan
blue dye exclusion . To achieve maximal viability, cells were washed with cold (4°C) growth medium
in a refrigerated (4°C) centrifuge . Cells grown in suspension culture were washed once in growth
medium before viral infection and three times before experimental testing .
For infection with virus, washed cells were mixed with measles virus at MOIs of 0.2-12.0 depending
on the experimental protocol . Viral adsorption was carried out in plastic tubes at 37°C for 2 to 4 h
with frequent mixing. Infected cells were then replated or resuspended under standard culture
conditions . In some instances, infected cells were grown on glass cover slips held in Petri dishes .
Monolayer cover slip cultures were prepared for immunofluorescence analysis by previously
published methods (6).
Immune Sera . Antisera used in this study were derived from human subjects with varying
histories of exposure to measles virus infection : (a) 12-moold infant, prevaccination ; (b)same child, 3
wk postmeasles vaccination ; (c) 3 children, acute epidemic measles ; (d) 3 male adults, distant
convalescent ; (e) 3 female adults, distant convalescent ; and (f) placental cord blood from newborns
from each of thepreceding women. In addition sera andcerebrospinal fluid from several patients with
SSPE were obtained from John Whitaker, University of Tennessee, Memphis, Tenn . ; Robert Roelofs,
Vanderbilt University, Nashville, Tenn . ; and John Sever, National Institute of NeurologicalBARRY S . JOSEPH, NEIL R. COOPER, MICHAEL B . A . OLDSTONE
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Diseases and Stroke, Bethesda, Md . In most cases, the fresh sera and spinal fluidsamples were stored
at -70°C .
Ig fractions from convalescent sera were prepared by previously reported techniques (7) and were
tested for purity at a concentration of 10 mg/ml by Ouchterlony analysis . Whereas IgG and IgM
isolates were immunochemically pure by these criteria, IgA isolates were contaminated with trace
amounts of IgG. Heavy chain-specific antisera to human IgG and IgA were obtained from Miles
Laboratories, Inc ., Miles Research Div ., Kankakee, Ill . Purified human myelomaIgAwasprovided by
Geraldine Meinke, Scripps Clinic and Research Foundation, La Jolla, Calif . All reagents were tested
for specificity by Ouchterlony analysis or immunoelectrophoresis . Igs were quantitated by the
Mancini radial immunodiffusion assay using Hyland test plates (Hyland Div., Travenol Laborato-
ries, Inc., Costa Mesa, Calif.) .
Antisera to HeLa cells were prepared in rabbits . Viable suspensions of 1 x 10 1 HeLa cells were
intraperitoneally injected into rabbits each week for 8 consecutive wk after an initial subcutaneous
priming with 1 x 10 1 HeLa cells in complete Freund's adjuvant . 1 wk after the final injection, sera
were collected, heat inactivated at 56°C for60 min, and stored in small aliquots at -70°C until use.
C and C Reagents .
￿
Freshly collected or fresh frozen human sera served as the sources of measles
antibody and of C for most of these studies . For some experiments, sera from humans congenitally
deficient in the second componentofC butcontaining measles antibody were employed . Our other C
sources for studies with Ig fractions, cerebrospinal fluids (CSF), or human immune sera previously
heated at 56°C for 30 min included serum from rhesus monkeys which lacked antibody to measles
virus and guinea pig serum which lacked antibody to measles virus and was deficient in the fourth
component of C .
In order to assess theparticipation of the alternative C pathway, humanserum washeated at 50°C
for 20 min, a procedure known to inactivate C3 proactivator, an essential component of the
alternative C pathway. This treatment yielded serum that was unable to sustain consumption of C3
on addition of inulin although full restoration of this activity wasachieved on addition of isolated C3
proactivator. A partial loss of classical pathway function resulted, since there was a 40-60%
impairment in ability to lyse sheep erythrocytes sensitized with antibody . C activity wasinterrupted
by incubation of 100 pl of serum with 6 rd of 0.2MEGTA, pH 7, and alternative pathway function
reconstituted by adding 6-pl aliquots of magnesium chloride at varying molarities as specified in the
Results . Both C pathways were inactivated by chelation of serum with 0.2M EDTA, pH 7, or by
heating of the sera at 56°C for 30 min .
Highly purified C3 proactivator wasisolated from humanserumaccording to the method of Gotze
and Miiller-Eberhard (8) and added in varying concentrations to serum depleted of alternative
pathway function by heating . Consumption of selected C components was determined after isolated
measles virus (approximate concentration of 500 jug/ml) was incubated with an equalvolume of fresh
human serum for 60 min at 37°C or after 1 x 10 5 HeLa cells infected with measles virus were
incubated with 400 ul of human serum for 60 min at 37°C . Methods employed to measure CH50, C1,
C2, C3, C4, C5, C8, and C9 quantitatively by hemolytic titration have been published (5, 9, 10) . The
integrity of the alternative C pathway after treatment of fresh convalescent sera with either
cell-bound or purified measles virus was assessed with three tests . First, inulin at a final
concentration of 10 ug/ml was added to measles treated and control sera . Second, the sera were
incubated with nephritic factor (C3NeF) (11) in a final concentration of 700 ug/ml . Third, the sera
were incubated with cobra venomfactor (12) in a final concentration of400ug/ml . After incubation at
37°C for 30 min, samples were assessed for residual C3 hemolytic activity .
Cytotoxicity Studies .
￿
A modification of the eosin micromethod (13) was used in most cases .
Briefly, 6-ul aliquots of fresh antiserum (antibody and C source) followed by 1-ul aliquots of cell
suspension (5 x 10 5/ml in growth medium) were discharged under mineral oil onto a Moller-Coates
plate (HTI Corp ., Associated Biomedic Systems, Buffalo, N. Y.) . In all experiments a control
consisting of cellsandheated serum (56°C, 30 min) was included .The plates were then incubated for
90 min at 37°C after which 1 Al of 5% eosin and then 1 Al of undiluted formaldehyde were added to
each reaction mixture. Viability was assessed by usingabinocular inverted-phase microscope with an
adjustable condenser (6-mm focal point) at a magnification of 200 . When different sources of
antibody and C were employed, the cells were incubated first with 2 ul of antibody solution
(previously heated at 56°C for 30 min),for 30 min at 37°C after which 6 u of C was added .
The results were expressed as a Cytotoxicity index that was corrected for nonspecific background
death of cells which never exceeded 5% . The Cytotoxicity index is defined as the percentage of cell764
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death observed in the experimental samples minus the percent of cells killed with heat-inactivated
human serum divided by 100 minus the percentage of cells killed with heat-inactivated serum.
Expression ofMeasles Virus Determined by Immunofluorescence.
￿
Fluoresceinated monospecific
antisera to human IgG, IgA, IgM, IgD, and IgE were furnished by Thomas Edgington, Scripps Clinic
and Research Foundation, La Jolla, Calif. HumanIgGseparated from sera ofpatients having measles
antibody was conjugated with fluorescein isothiocyanate (FITC) as described elsewhere (14). The
monospecificity of each antisera wasverified by Ouchterlony analysis and by immunoelectrophoretic
testing.
For staining measles virus antigens expressed on the cell surface, 1-4 x 105 infected HeLa cells
were resuspended and washed as described earlier and incubated with 50 ul of FITC-IgG antibody to
measles virus for 30 min at room temperature. Cells were then washed twice in medium and examined
for surface fluorescence with a Zeiss RA fluorescence microscope (Carl Zeiss, Inc., New York) . The
expression of measles virus antigens inside the cell wasdetermined as above except that the cells were
fixed in ether: 95% ethanol before staining as described (6).
Expression of Measles Virus on the Cell Surface Determined by Binding of Radiolabeled
Antibody. HeLa cells were infected with measles virus at a MOI of 12.0 and plated in separate
Falcon flasks . At various intervals after initiation of infection the cells were dissociated, washed, and
1 million cells incubated with identical amountsof deaggregated (15) "II-radiolabeled antibody (16) to
measles virus for 60 min at room temperature. The cells were then washed five times in growth
medium and the cell pellet counted in a Baird Atomic gamma counter (Baird Atomic, Inc., Bedford,
Mass.). Specific labeling was obtained by subtracting the number of counts adhering to 1 million
uninfected HeLa cells treated in an identical manner. The amount of antibody molecules bound on
the surface of the infected cells at each interval was determined from the specific activity of the
radiolabeled antibody fraction and the number of cells used in the assay.
Immunoabsorption .
￿
Separate globulin fractions of goat sera containing antibody to human IgG
andto human IgA were prepared by ammonium sulfate precipitation . After dialysis, lyophilization,
andreconstitution to 500 ug/ml, 40 A1 were mixed with a 15-ul aliquot of neat convalescent measles
serum and a5-jul aliquot of purified human
['25I ]IgG or ['25I ]IgA. A single SSPE serum wastreated in
an analogous manner. Each mixture was incubated in a Beckman microf'uge tube (Beckman
Instruments Inc., Fullerton, Calif.) at 4°C for 7 days after which the precipitates were removed by
centrifugation. Under these conditions, over 99% precipitation of the radiolabeled IgGor IgAtracers
wasobtained. Supernates from each reaction mixture were titered for residual cytolytic activity using
a source of C devoid of measles virus antibodies .
Results
Antibody and C-Mediated Lysis of Cells Infected with Measles Virus. HeLa
cells were susceptible to infection with Edmonston strain measles virus as
evidence by the appearance of viral antigens in the cytoplasm and on the cell
surfaces within 24 h after the addition of virus to the cultures . With a low M01,
generalized cytopathic effects, i.e . giant cell formation and membrane fusion,
were evident by the 5th and 6th days after infection. When fresh undiluted sera
from patients who were convalescent from measles infection, chronically infected
with measles (SSPE), or recently immunized against measles viruswere added to
infected cells 48 h or more after initiating infection, cell lysis occurred . Prior
heating of these sera for 30 min at 56°C abrogated the lytic effect, although
heated sera could initiate lysis on the addition of a fresh source of C devoid of
antibody(s) to measles virus. The specificity of the lytic process was shown both
by the failure of these fresh sera to lyse uninfected HeLa cells and by their
inability to damage infected cells after absorption with measles virus. Similar
results were obtained with sera having antibodies to measles virus and taken
from infants shortly after birth. When dilutions of sera were employed with
Rhesus monkey serum as the C source, the 50% cytotoxic end point varied fromBARRY S. JOSEPH, NEIL R. COOPER, MICHAEL B . A. OLDSTONE
￿
765
1/4 to 1/64 for convalescent patients and from 1/256 to >1/1,000 for sera from
patients with SSPE .
Other epithelial cells lines (KB, andH.Ep . no . 2) as well as neuroblastoma
(IMR-32), glioma (339 MG), and lymphoid cells line (RPMI 8866, Raji) were also
readily infected by Edmonston strain measles virus . Similarly, these cells were
lysed by antimeasles virus antibody(s) in conjunction with C. HeLa cells infected
with three other strains of measles virus (M-VAC, Schwarz, and SSPE-Halle)
manifested the same phenomena .
Expression of Measles Virus Antigens in Relation to Antibody- and C-
Mediated Lysis of Cells Infected with Measles Virus . HeLa cells were infected
with a lowMOI ofEdmonston strain measles virus (0 .2) and examined at various
times for the presence of measles virus antigens . As seen in Fig . 1, viral antigens
were first noted in the cytoplasm and on the plasma membrane approximately 18
h after infection began, and the percentage of cells expressing measles virus
FIG. 1 .
￿
Time-course of expression of measles virus antigens in the cytoplasm and on the
surface of HeLa cells andrelationship to susceptibility to antibody and C-mediated cytolysis .
Cells were infected at an MOI of 0.2 and sampled at intervals . Cytoplasmic (") and surface
(O) expression of measles virus antigens are shown as the percentage of cells demonstrating
fluorescence while cytotoxicity (") is shown as a cytotoxicity index .
antigens increased throughout the period of observation . In the same experiment,
antibody- and C-mediated injury of these cells were first observed 36 h after the
initiation of infection. Thereafter, the number of infected cells lysed increased
directly in parallel with the number of cells showing measles virus antigens . By
96 h after infection began, all cells expressed virus antigens on theirsurface and
82% were lysed by antibody and C, and all cells were susceptible to lysis 100 h
after infection .
Ig Class Initiating C-Mediated Lysis of Cells Infected with Measles Virus .
￿
In
order to determine the class of antimeasles virus Ig(s) present in immune sera,
infected HeLa cells were incubated with heated (56°C, 30 min) serum from
individuals convalescent from measles infection, from patients chronically
infected with measles virus (SSPE), and from children having an acute measles
virus infection . After washing, the cells were incubated with FITC-labeled
monospecific antisera to IgG, IgA, IgM, IgD, and IgE. These studies showed the
presence of IgG, IgA, and IgE measles antibodies in all sera tested . Sera from766
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patients with acute measles contained, in addition, IgM antibody . No serum was
found to contain antibody of the IgD class .
To determine whether IgG or IgA was responsible for antibody-initiated,
C-mediated lysis in convalescent and SSPE sera, IgG and IgA were immuno-
precipitated with monospecific antisera . As shown in Fig . 2, the removal of over
99% ofIgG led to an eight-fold or greaterreduction in the ability of sera to initiate
lysis with a fresh source of monkey C devoid of measles virus antibodies . Studies
performed with sera similarly depleted ofIgA showed no decrease in the cytotoxic
titer (Fig . 2) .
In other experiments, IgG, IgA, and IgM were partially purified from
convalescent sera, concentrated, and examined for their ability to induce lysis of
infected HeLa cells in the presence of a source of human C lacking measles virus
FIG. 2 .
￿
Effect of depletion of IgG and IgA from sera containing antibodies to measles virus
and the cytolytic potential of such sera in conjunction with afresh source ofC. Lysis associated
with convalescent human serum (panel a) and SSPE serum (panel b) was significantly
reduced by depletion of IgG but not depletion of IgA.
antibody . Only the IgG fraction was able to initiate lysis, although its titer in this
regard was lower than that present in the starting serum . The IgG fraction
contained over 90% of the hemagglutination inhibition activity present in the orig-
inal convalescent serum. IgA and IgM fractions in the presence ofC were unable
to initiate lysis when examined in concentrations two- to threefold greater than
those present in starting serum .
Quantitation of the Amount of IgG Antibody Required to Lyse Cells Infected
with Measles Virus . HeLa cells in culture were sampled at varying times after
infection (MOI, 12.0) and examined by immunofluorescence for surface expres-
sion of measles virus antigens . At the same time intervals, cells were incubated
with [1151]IgG isolated from aconvalescent human serum . Concurrently, a paired
aliquot of cells was assayed for lysis after the addition of antimeasles virus
antibody and C . As shown in Table I, 85% of cells were found to have measles
virus antigens on their surfaces by 20 h after infection . At this time, although
these cells expressed sufficient measles virus antigens to bind 1 .1 x 10 6 molecules
of IgG per cell, antibody and C were not sufficient to lyse cells in the pairedBARRY S . JOSEPH, NEIL R. COOPER, MICHAEL B. A. OLDSTONE
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TABLE I
Number of Antibody Molecules Required to Lyse
Virus-Infected Cells
*Expression of virus antigen(s) on the surface of living cells was
determined by direct immunofluorescence using FITC-labeled human
antibody to measles virus, while immune lysis was observed with the
microcytotoxicity assay . Approximately 200 cells were counted in each
sample .
$HeLa cells were infected at MOI of 12 .
§ Sp act of IgG used was 3.74 x 10 5 cpm/kg protein .
~~ Number calculated from the 15,488 "II-labeled cpm binding to 1 x 10 8
cells .
sample . C-mediated lysis was first observed 24 h after infection. At this time 2.0
x 106 molecules ofIgG were bound per cell (Table 1) .Cwas able to induce lysisof
all the cells by 48 h after infection when the cells bound at least 5 .1 x 10 6
molecules of IgG per cell .
C Pathway Inuolued in Antibody-Initiated Lysis .
￿
The cytolytic activity of C
for IgG antibody-coated HeLa cells infected with measles virus and expressing
viral antigens on their surfaces (sensitized, infected HeLa cells) was extremely
sensitive to dilution, with approximately half of the cytolytic activity being lost
by using a 1:2 dilution of the C source and over 90% by using a 1:4 dilution . In
contrast, cytolytic activity of the same C source for uninfected HeLa cells coated
with rabbit anti-HeLa antibody(s) was considerably less sensitive to dilution
since half of the original cytolytic titer remained with the C source diluted to
1:50 .
Evidence that C-mediated lysis of sensitized, infected HeLa cells required
magnesium but not calcium was obtained from studies in which increasing
amounts ofMg were added to serum chelated with 1 .1 x 10-IM EDTA or EGTA .
Whereas EDTA effectively chelates Ca and Mg, EGTA has a 10,000-fold lower
affinity for Mg and thus is a relatively selective chelator of Ca . No lysis was
observed with EDTA-chelated serum until a final concentration of6.4 x 10-3M
Mg had been added, and complete lysis occurred only on addition of 1.28 x 10- Z
M Mg (Fig . 3) . In contrast, the addition of small amounts of Mg to EGTA-
chelated serum rapidly restored lytic ability to the serum . Lysis was observed on
addition of 7 .5 x 10-4MMg and complete lysis occurred with 1 .5 x 10-3M Mg .
No Mg ion dependency was noted in the lysis of HeLa cells during incubation
with antibody to HeLa cell surface and C .
H after$
infection
Percent
Expressing
viral antigens
ofcells*
Lysed by
antibody +C
Molecules of
specific§
antibody
bound/cell
4 0 <5 1.5 x 10 5 11
20 85 <5 1.1 x 10 8
24 95 20 2.0 x 10 8
36 100 70 ND
48 100 100 5.1 x 10 8768
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Final Magnesium Concentration (Mx10-3 )
FIG. 3. Dependence of antibody-mediated C-dependent lysis of HeLa cells infected with
measles virus on magnesium. Sera were chelated with 1.1 x 10-2MEGTA (") or EDTA (A)
andrestored with varying concentrations of magnesium chloride . Theabscissa shows the final
concentration of added magnesium chloride .
These studies strongly suggested that the alternativeC pathway was responsi-
ble for lysis of sensitized, infected HeLa cells . In order to confirm this impression,
serum was heated at 50°C for 20 min, a treatment that leads to relatively
selective inactivation of C3 proactivator, a central factor in the alternative C
pathway . Serum heated in this manner was completely devoid of the ability to
lyse sensitized, infected HeLa cells . Inactivation of the alternative C pathway
was documented in independent studies in which the heated serum was unable to
sustain conversion of C3 on addition of inulin ; the classical pathway, however,
was relatively intact since the heated serum retained approximately 40% of its
original ability to lyse sensitized sheep erythrocytes . As shown in Fig . 4, the
addition of amounts of highly purified C3 proactivator comparable to those
present in normal serum (200 jug/ml) fully reconstituted the cytolytic ability of
the heated serum .
To assess any role of the classical C pathway, human serum genetically
deficient in the second component ofC but containing antibody to measles virus
was examined for its ability to lyse sensitized, infected HeLa cells . C2-deficient
serum was fully active in this regard . As observed with normal serum, heating of
C2-deficient serum at 50 °C for 20 min abrogated its cytolytic ability, and this
effect was reversed on addition of physiological amounts of purified C3
proactivator . Guinea pig serum deficient in C4 could also lyse infected HeLa cells
presensitized with IgG antibody to measles virus .
Consumption of components in serum previously incubated with infected
HeLa cells also revealed a pattern consistent with alternative pathway activa-
tion . Insignificant consumption of C1 (8%), C4 (0%), and C2 (14%) occurred,
whereas consumption of C3 (37%) and C5 (42%) was significant .
C Pathway Involved in Lysis of Several Cell Lines Infected with Various
Measles Viruses . Lysis of HeLa cells infected with M-Vac, Schwarz, or
SSPE-Halle strains of measles virus and sensitized with IgG antibodies to
measles virus was also found to proceed via the alternative C pathway since lysis
was abrogated by heating of the C source at 50°C for 20 min and restored on
addition of physiological amounts of purified C3 proactivator . Similar experi-
ments showed that infected epithelial (HeLa, KB, andH.Ep. no . 2), neuroblas-
toma (IMR-32), glia (339 MG), and lymphoid (RPMI 8866, Raji) cell lines
sensitized with antibody from convalescent human sera were lysed via the
alternative C pathway.BARRY S . JOSEPH, NEIL R . COOPER, MICHAEL B . A . OLDSTONE
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FIG . 4 .
￿
Restoration by isolated C3 proactivator of antimeasles virusimmunocytolytic activity
to serum which had been previously heated at 50°C for 20 min. Full cytolytic activity was
restored with physiological amounts of C3 proactivator (200 rag/ml) .
Interaction of Antibody and C with Purified Measles Virions . Purified
measles virus was found to activate the classical C pathway . Thus when purified
virus was mixed with fresh human convalescent serum, significant consumption
of CH50 (>90%), C1 (47%), C4 (70%), C2 (>96%), C3 (33%), C5 (31%), C8 (11%),
and C9 (27%) occurred . Further, consumption of C1 (38%) and C4 (45%) was
observed on incubation of measles virus with a C2-deficient human serum
containing antibodies to measles virus ; borderline consumption of C3 (19%) and
C5 (10%) with no depletion of C8 or C9 was also observed . In order to determine
whether components of the alternative C pathway had been similarly depleted,
the ability of normal and C2-deficient sera previously incubated with isolated
measles virus to sustain C3 consumption on incubation with three different
activators of the alternative pathway was determined . Each of the activators
selected, inulin, cobra venom factor, and C3NeF which initiate the alternative
C pathway at different sites in the sequence was able to trigger comparable C3
depletion regardless of whether or not the sera had been previously incubated
with measles virus (Table II) . Reduced levels of consumption by one or more of
these activators would have been expected if components of the alternative C
pathway had been depleted by incubation with measles virus .
Discussion
A number of human cell lines including epithelial (HeLa, KB, and H.Ep . no . 2), neuro-
blastoma (IMR-32), glia (339 MG), and lymphoid (RPMI 8866, Raji) cells infected with
wildtype Edmonston measles virus were lysed upon the addition of fresh convalescent
serum. Antibody-initiated, C-mediated injury in this entirely homologous model of acute
measles virus infection also occurred in cells infected with SSPE-Halle, Schwartz, or M-
Vac measles virus . Immune sera from patients with either acute measles virus infection,
SSPE, recent measles vaccinations, or histories of measles virus infection and convales-
cence lysed HeLa cells infected with Edmonston measles virus . Hence it is clear that
humorally mediated injury of cells infected with measles virus is not restricted to one
particular cell line, strain of virus, or clincal state of measles virus infection . Earlier
studies mainly with heterologous systems showed that infected cells expressing virus
antigens on their surfaces may be destroyed through the action of antiviral antibody and
C . For example, humorally mediated injury has been reported with rabies (17), dengue770
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TABLE II
Integrity of the Alternative Pathway in Human Serum after
Incubation with Purified Measles Virus
Second incubation
Normal serum :
C2-deficient serum:
* Normal or C2-deficient serum were incubated first with measles virus
which led to 33 or 19% consumption of C3, respectively. The percent
consumption of the residual amounts of C3 on addition of inulin, cobra
venom factor (CoF), or C3NeF was then assessed.
(18), Newcastle disease (19), SV-5 (20), murine leukemia (21, 22), herpes simplex (19),
vaccinia (19), influenza (19), lymphocytic choriomeningitis (23), mumps (23), and
measles (24, 25) viruses.
In the present studies the mechanisms involved when HeLa cells acutely infected
with measles virus were lysed by human antibody and C were analyzed .
IInmunofluorescent-staining experiments showed that convalescent and SSPE
serum contained antibody directed against measles virus of the IgG, IgA, and IgE
classes and serum from patients afflicted with an acute measles infection
contained in addition IgM antibody. IgG antibody to measles virus initiated
C-dependent lysis of infected cells as immunospecific depletion of IgG led to
virtually total abrogation of cytolytic activity whereas similar depletion of IgA
was without effect .
High concentrations of cell-bound IgG were associated with lysis. Lysis was first observed
24 h after infection when cells express sufficient virus antigens to bind at least 2 x 10'
molecules of IgG per cell. Immune lysis was not obtained during measles virus adsorption
even at high hemadsorption to target cell ratios or with using Rhesus monkey erythrocytes
First
incubation
Activator
Depletion
ofC3*
Measles Inulin 54
Buffer Inulin 36
Measles CoF 96
Buffer CoF 96
Measles C3NeF 92
Buffer C3NeF 97
Measles Inulin 36
Buffer Inulin 40
Measles CoF 92
Buffer CoF 98
Measles C3NeF 71
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as target cells (B. Joseph and M. B. A. Oldstone, unpublished data) . All the cells were
lysed 48 h after infection when test cells bound 5.1 x 108 or more molecules of IgG per cell .
The requirement for high concentrations of cell-bound IgG may reflect an inefficiency of
IgG in activation of C for cytolysis of infected HeLa cells, or the existence within the IgG
fraction of only a minor proportion of IgG, perhaps subclass, which is capable of initiating
lysis. Alternatively, it may be that measles virus antigens were initially expressed on
portions of the cell surface which are resistant to C-dependent injury and only with
prolonged infection is the virus expressed on regions of the membrane susceptible to lysis.
It is also possible that virus directed alterations in the plasma membrane or in the ability
to repair C-dependent damage modifies the susceptibility of the cell to immune attack.
Recent studies with lymphocytes have demonstrated cell cycle-dependent alterations in
antiviral immunolytic susceptibility which indicate that the cell membrane plays an
active role in determining the outcome of a potentially cytolytic process (26-28) . It is
unlikely that this inefficiency in initiating lysis is due to saturation of the cell surface with
antibody which is inefficient in triggering lysis because of the high concentration, since no
prozone in regard to lysis was observed in dilutional studies of convalescent or SSPE sera
which contained higher concentrations of IgG antibody than that present in the isolated
fraction employed for the radioactive-binding studies .
Antibody-initiated injury of cells infected with measles virus was found to be
mediated by the alternative C pathway . The evidence in support of this
contention derives from studies which showed that brief heating at 50°C of the C
source which leads to a relatively selective inactivation of an essential factor of
the alternative C pathway, C3 proactivator, completely prevented lysis. Full
cytolytic activity was restored by supplementation with physiological amounts of
highly purified human C3 proactivator . Serum genetically deficient in C2 and
possessing measles virus antibody showed full cytolytic potential, demonstrating
no essential role for the classical C pathway in this lytic reaction. Lysis produced
by C2-deficient serum also was abrogated on heating on 50°C for 20 min and
restored by addition of purified C3 proactivator.
These studies represent the first demonstration of an alternative C pathway-
mediated cytolytic event initiated by human antibodies of the IgG class. Other
studies have shown that this pathway is directly activated by certain naturally
occurring polysaccharides and by aggregates of human IgA2 and IgE (29)
myeloma proteins but similar aggregates of IgG myelomas have not been found to
be effective.2 In animals, however, guinea pig -y,-Ig in complex with antigen has
been shown to activate the alternative C pathway as has cell-bound rabbit IgG
antibody in high concentration (30, 31) .
All human sera tested with the exception of a 12-mo old infant which lacked measles-
specific IgG antibody were shown to possess totally endogenous immunocytolytic
potential against cells infected with measles virus . Lysis was also observed with serum
taken from infants shortly after birth, documenting the integrity of the alternative C
pathway at this stage in development. Sera and CSF from patients with SSPE was
effective in lysing measles virus-infected cells indicating the presence of cytolytically
effective antibody and the integrity of the alternative C pathway in patients with this
disease. In other experiments not presented here, brief pretreatment of infected cells with
' Miiller-Eberhard, H. J., O. Gotze, and H. L. Spiegelberg. 1975. Activation of the alternative
pathway by immunoglobulin aggregates and bacterial substances . Manuscript in preparation .772
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heated (56°C, 30 min) SSPE serum or CSFdid not prevent subsequent lysis on addition of
freshly thawed convalescent serum. Thus, no evidence for adefect in cytolytic antibody or
the C system, or evidence for a blocking factor, was found in the serum or spinal fluid of
patients with SSPE to account for the persistant viral infection which occurs in this
disease.
Of interest is the fact that uninfected HeLa cells incubated with rabbit antibody
prepared against HeLa cell surface antigens were found to be lysed by the
classical C pathway. These studies amplify earlier work which showed that C and
antibody to measles virus in a heterologous system could lyse HeLa cells infected
with measles virus (25). In this study, lysis was abrogated at low dilutions of C in
contrast with effective lysis with antibodies to HeLa cell surface at similar or
greater dilutions of C. Equivalent results were obtained in our own studies.
Differential activation of C by sensitized cells has also been noted in the HL-A
system (32) .
In contrast to the requirement for the alternative C pathway in lysing measles
virus-infected cells, purified measles virus was found to trigger the classical C
pathway on incubation with the same source of immune human serum. The C
consumption studies failed to reveal significant evidence for activation of the
classical C pathway by measles-infected cells and conversely, isolated measles
virus appeared to be unable to significantly activate the alternative C pathway
(Table II). The reason for this apparent utilization of different C pathways
depending on whether measles virus is in the isolated form or expressed on cell
membranes is not clear at present but it is tempting to speculate that the
membranes of the infected cells provide an essential additional stimulus which
serves to activate the alternative C pathway. This might occur if human sera
possessed antibody to virus-induced but nonviral-associated antigens on the cell
surface or antibody directed against unmasked surface antigens generatedduring
virus maturation at the cell surface. We are currently evaluating whether this
phenomenon occurs with other human viruses which bud from the cell surface.
Summary
In these studies, a number of human cell lines including epithelial, neural, glial,
and lymphoid cells infected with several strains of measles virus were found to be
lysed upon incubation with fresh sera from humans containing antibody to
measles virus. In all instances, the cytolytic event was mediated by the
alternative complement (C) pathway without a significant contribution from the
classical pathway. In contrast, isolated measles virus in conjunction with
antibody was found to selectively activate the classical C pathway.
Measles antibodies of the IgG class, but not the IgA class, possessed cytolytic
potential against cells infected with measles virus. Human IgG antibodies could
directly activate the alternative C pathway.
No defect was found in cytolytic measles antibody in sera or cerebrospinal fluid
from patients with subacute sclerosing panencephalitis, nor was the alternative C
pathway impaired in sera from these patients. Sera from newborn humans also
exhibited a functional alternative C pathway.BARRY S . JOSEPH, NEIL R. COOPER, MICHAEL B. A. OLDSTONE
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